Immune to Cancer: The CRI Blog
-
Unraveling the Pro-Tumorigenic Myelopoiesis Driven by an IL-4 Signaling Axis in Bone Marrow
CRI is delighted to share the latest milestone achievement from CRI-supported investigators at Icahn School of Medicine… -
CRI Immunologists Are Armed Against Lung Cancer, the Most Common Cancer Worldwide
A Large Cancer Presence on a Global Scale The Cancer Research Institute (CRI) has a singular focus:… -
How CRI is Taking on Pancreatic Cancer, “The Silent Killer”
Immunotherapy holds the greatest promise for optimizing outcomes for cancer patients, and eventually finding a cure for… -
How to Help CRI Raise Money for Crucial Cancer Immunotherapy Research This Giving Tuesday
“GivingTuesday is an opportunity for people around the world to use their individual power of generosity to… -
CRI Hosts 2023 Annual Awards Dinner, Bestows Coley and Alt Awards on Immunotherapy Giants
NEW YORK — On November 6, 2023, the Cancer Research Institute (CRI) hosted its 2023 Annual Awards… -
CRI Provides Latest Overview of the Field of PDx Trials
PD1 and PDL1 inhibitors, collectively referred to as PDx, have revolutionized cancer treatment since the approval of… -
6 CRI-Affiliated Scientists Elected to the National Academy of Medicine
The National Academy of Medicine (NAM), an organization that has worked on critical issues at the intersection… -
3 Runners on Why They are Fundraising for a Future Immune to Cancer with Team CRI at the TCS New York City Marathon
There are a variety of great ways to fundraise on behalf of the Cancer Research Institute (CRI),… -
New Horizons Opened by Research and Generous Support
A Conversation with Esther M Baird – Passionate Supporter of CRI Research Programs Why is funding scientists…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.